IMRX Immuneering Corp Forecast, Technical & Fundamental Analysis

Industry Biotechnology

Get AI intraday signals

IMRX

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if shorted

View Trends For IMRX
(Try 14 days for Free)

View a ticker or compare two or three

Compare

IMRX

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if shorted

View Trends For IMRX
(Try 14 days for Free)

Ad is loading...

A.I. Advisor

published Earnings

IMRX is expected to report earnings to rise 17.02% to -55 cents per share on November 13

Immuneering Corp IMRX Stock Earnings Reports

Q3'24

Est.

$-0.55

Q2'24

Beat

by $0.05

Q1'24

Beat

by $0.01

Q4'23

Missed

by $0.06

Q3'23

Beat

by $0.06

The last earnings report on August 06 showed earnings per share of -46 cents, beating the estimate of -51 cents. With 1.48M shares outstanding, the current market capitalization sits at 57.53M.

A.I. Advisor

published General Information

General Information

Industry Biotechnology

Profile

Fundamentals

Details

Industry

N/A

Address

245 Main Street

Phone

+1 617 500-8080

Employees

Web

https://www.immuneering.com

Interesting Tickers

STOCK / NAME	Price $	Chg $	Chg %
		1 Day
GNTY	36.22	0.83	+2.35%
Guaranty Bancshares
EPD	30.81	0.42	+1.38%
Enterprise Products Partners LP
HLIO	50.52	-0.53	-1.04%
Helios Technologies
STRL	182.39	-4.26	-2.28%
Sterling Infrastructure
GP	0.82	-0.07	-7.48%
GreenPower Motor Company

IMRX and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, IMRX has been loosely correlated with SPRB. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if IMRX jumps, then SPRB could also see price increases.

Ticker / NAME	Correlation To IMRX	1D Price Change %
IMRX	100%	-6.56%
SPRB - IMRX	49% Loosely correlated	-2.78%
NUVL - IMRX	38% Loosely correlated	-0.89%
INSM - IMRX	30% Poorly correlated	+0.66%
ORMP - IMRX	29% Poorly correlated	-0.64%
SRRK - IMRX	29% Poorly correlated	+2.70%
More